Standout Papers

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepa... 2014 2026 2018 2022 418
  1. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma (2014)
    Rita Golfieri, Emanuela Giampalma et al. British Journal of Cancer
  2. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma (2017)
    Vincenzo Mazzaferro, Carlo Sposito et al. Gastroenterology
  3. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection (2018)
    Anthony W.H. Chan, Jian‐Hong Zhong et al. Journal of Hepatology

Immediate Impact

3 from Science/Nature 140 standout
Sub-graph 1 of 15

Citing Papers

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
89 intermediate papers

Works of Alessandro Cucchetti being referenced

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014 Standout
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
2013
and 41 more

Author Peers

Author Last Decade Papers Cites
Alessandro Cucchetti 7043 4341 4121 260 9.9k
Matteo Cescon 6700 4721 3959 303 9.9k
Paul D. Greig 7400 6145 4019 240 10.9k
Giorgio Ercolani 5741 5056 3338 347 9.4k
Matteo Ravaioli 5057 4000 2719 273 8.0k
Karim Boudjéma 4902 4631 1642 285 8.7k
Olivier Soubrane 6534 6495 2750 369 12.1k
Julie K. Heimbach 11955 8192 8036 226 18.3k
Gonzalo Sapisochín 3727 3007 1833 183 6.0k
Denis Castaing 13619 9349 4835 202 17.4k
Shimul A. Shah 2743 3942 1557 272 7.3k

All Works

Loading papers...

Rankless by CCL
2026